Creandum led the Series A round with participation from Peter Thiel, firstminute, Seedcamp, Hambro Perks and Amino Collective.
"Clinical trials are the biggest bottleneck to improving human health. We deliver clinical trials three times faster than the industry standard, working with biotech pioneers to get new treatments to patients more quickly."
The London-based clinical trials platform has secured $6m to date from high-profile investors.
"Clinical trials are the biggest bottleneck to improving human health. We’re working with high-growth companies developing the next wave of breakthrough treatments to accelerate the clinical trials process."
Bonnier Ventures led the Series A round to fund the rollout of the proprietary Kyra Platform.
"We built Kyra to help brands authentically connect with Gen Z on TikTok, and we’re excited to deploy our Series A capital to launch the Kyra Platform and alleviate challenges within the creator economy,"
The seed round was backed by investors including Firstminute Capital, Presight Capital, and Seedcamp.
"Traditional clinical research companies are dinosaurs. Taking part in a COVID vaccine trial was like stepping into a time machine. This was one of the best funded trials in history but research was done on pen and paper and participants had to go into hospital at the height of the pandemic to fill out forms. We founded Lindus Health to make it easier for patients to participate in research, and accelerate the development of new treatments."